Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

0.9727 -0.0573 (-5.56%)

Streaming Delayed Price Updated: 2:51 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nautilus Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

February 21, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

January 26, 2023

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Expands to San Diego

January 26, 2023

Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Recap: Nautilus Biotechnology Q3 Earnings ↗

November 01, 2022

Nautilus Biotechnology (NASDAQ:NAUT) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Nautilus Biotechnology Q2 Earnings ↗

August 02, 2022

Nautilus Biotechnology (NASDAQ:NAUT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For November 2, 2021 ↗

November 02, 2021

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...

Via Benzinga

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

January 19, 2023

Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus’ next-generation proteome analysis platform to advance the study of a rare childhood cancer

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

December 13, 2022

On Tuesday, 49 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

Nautilus Biotechnology Launches “First Access Challenge”

November 16, 2022

Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis...

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

November 01, 2022

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

October 05, 2022

From Nautilus Biotechnology Inc.

Via GlobeNewswire

$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

August 23, 2022

The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 19, 2022

Via Benzinga

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗

August 22, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.

Via Benzinga

$1.2 Million Bet On Gannett? Check Out These 3 Penny Stocks Insiders Are Buying ↗

August 09, 2022

U.S. stock futures traded slightly higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Preview Of Nautilus Biotechnology's Earnings ↗

August 01, 2022

Nautilus Biotechnology (NASDAQ:NAUT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 21, 2022

Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022 ↗

January 06, 2022

Upgrades For Canada Goose Holdings Inc (NYSE:

Via Benzinga

50 Biggest Movers From Yesterday ↗

December 23, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ: ACST) jumped 52.3% to close at $1.69 on...

Via Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session ↗

December 22, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United...

Via Benzinga

Cramer Shares His Thoughts On Incyte, Corning And More ↗

December 22, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Incyte Corporation (NASDAQ:

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 14, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021 ↗

November 02, 2021

Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

Bet On Biopharma: Data, Digitization, Discovery ↗

October 16, 2021

The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the...

Via Talk Markets

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.